AVIVAC – IB+ND
AVIVAC – IB+ND
Authorised
- Avian infectious bronchitis virus, type Massachusetts, strain H120, Live
- Newcastle disease virus, strain La Sota, Live
Product identification
Medicine name:
AVIVAC – IB+ND
АВИВАК – ИБ+НБ
Active substance:
- Avian infectious bronchitis virus, type Massachusetts, strain H120, Live
- Newcastle disease virus, strain La Sota, Live
Target species:
-
Chicken
Route of administration:
-
Intranasal use
-
Oral use
-
Nebulisation use
Product details
Active substance and strength:
-
Avian infectious bronchitis virus, type Massachusetts, strain H120, Live3.50/log 10 50% embryo infective dose1.00Dose
-
Newcastle disease virus, strain La Sota, Live6.50/log 10 50% embryo lethal dose1.00Dose
Pharmaceutical form:
-
Lyophilisate for suspension
Withdrawal period by route of administration:
-
Intranasal use
-
Chicken
-
-
Oral use
-
Chicken
-
-
Nebulisation use
-
Chicken
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI01AD11
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Bulgaria
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - New active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Mintech Co EOOD
Marketing authorisation date:
Manufacturing sites for batch release:
- Mintech Co EOOD
Responsible authority:
- BFSA
Authorisation number:
- 0022-3134
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Bulgarian (PDF)
Published on: 26/08/2022
Package Leaflet and Labelling
This document does not exist in this language (English). You can find it
in another language below.
Bulgarian (PDF)
Published on: 26/08/2022
How useful was this page?:
